J1954, injection, leuprolide, (Lutrate), 7.5 mg, is available for all sites of care – 1/4/23

[et_pb_section fb_built=”1″ theme_builder_area=”post_content” _builder_version=”4.19.4″ _module_preset=”default”][et_pb_row _builder_version=”4.19.4″ _module_preset=”default” theme_builder_area=”post_content”][et_pb_column _builder_version=”4.19.4″ _module_preset=”default” type=”4_4″ theme_builder_area=”post_content”][et_pb_code _builder_version=”4.19.4″ _module_preset=”default” theme_builder_area=”post_content” hover_enabled=”0″ sticky_enabled=”0″] /* OUTLOOK-SPECIFIC STYLES */ li { text-indent: -1em; padding: 0; margin: 0; /* line-height: 1.2; Remove after testing */ } ul, ol { padding: 0; margin: 0 0 0 40px; } p { margin: 0; padding: 0; margin-bottom: 0; } Effective January 1, 2023: J1954 The unique HCPCS code for Cipla USA’s LEUPROLIDE ACETATE INJECTION DEPOT (Leuprolide Acetate for Depot Suspension)

Effective January 1, 2023:


J1954, injection, leuprolide, (Lutrate), 7.5 mg, is available for all sites of care.


J1954 is a unique HCPCS code for Cipla’s version of LEUPROLIDE ACETATE INJECTION DEPOT (Leuprolide Acetate for Depot Suspension) and should not be used for billing other leuprolide formulations.

HCPCS

Code

HCPCS Code

Descriptor

NDC

Number

Strength

WAC Per Package

HCPCS Units Per Package

J1954

injection, leuprolide, (Lutrate), 7.5 mg

69097-0909-50

22.5 mg

$1,355.07

3

We respectfully request the update of all claims and reimbursement systems to include the new coding information for injection, leuprolide, (Lutrate), 7.5 mg,

effective January 1, 2023


Please contact us @ Account.Management@Cipla.com


© Copyright 2022 Cipla USA Inc. All rights reserved


December 2022   CUSAI-12012022-02